Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 4,701,000 | 5,065,000 | 5,398,000 | 5,617,000 | 5,720,000 |
| Cost of Goods | 2,668,000 | 2,750,000 | 3,127,000 | 2,967,000 | 2,865,000 |
| Gross Profit | 2,033,000 | 2,315,000 | 2,271,000 | 2,650,000 | 2,855,000 |
| Operating Expenses | 1,927,000 | 790,000 | 15,288,000 | 2,272,000 | 8,595,000 |
| Operating Income | 106,000 | 1,525,000 | -13,017,000 | 378,000 | -5,740,000 |
| Other Income | -348,000 | -345,000 | -184,000 | -262,000 | -252,000 |
| Pre-tax Income | -242,000 | 1,180,000 | -13,201,000 | 116,000 | -5,992,000 |
| Income Tax | -76,000 | 46,000 | -1,471,000 | -494,000 | -22,000 |
| Net Income Continuous | -166,000 | 1,134,000 | -11,730,000 | 610,000 | -5,970,000 |
| Minority Interests | 10,000 | 14,000 | -195,000 | 15,000 | N/A |
| Net Income | $-176,000 | $1,120,000 | $-11,535,000 | $595,000 | $-5,970,000 |
| EPS Basic Total Ops | -0.24 | 1.04 | -11.41 | 0.52 | -5.94 |
| EPS Basic Continuous Ops | -0.16 | 1.12 | -11.55 | 0.60 | -5.87 |
| EPS Diluted Total Ops | -0.24 | 1.03 | -11.41 | 0.52 | -5.94 |
| EPS Diluted Continuous Ops | -0.16 | 1.11 | -11.55 | 0.60 | -5.87 |
| EBITDA(a) | $585,000 | $2,032,000 | $-12,489,000 | $905,000 | $-5,163,000 |